adolesc
uniqu
sometim
challeng
time
young
person
life
time
mark
transit
childhood
adulthood
exemplifi
cognit
psychosoci
emot
develop
well
physic
pubert
growth
furthermor
adolesc
tri
gain
independ
creat
secur
ident
critic
time
howev
unparallel
growth
physic
cognit
psychosoci
develop
may
limit
adolesc
abil
perceiv
judg
risk
appropri
fig
depict
interdepend
development
achiev
adolesc
cognit
develop
adolesc
includ
develop
advanc
reason
skill
abil
think
abstractli
also
capac
think
other
perceiv
result
formal
oper
thought
disclosur
none
keyword
adolesc
liver
diseas
nonalcohol
fatti
liver
diseas
hepat
challeng
must
address
effect
care
liver
diseas
adolesc
also
patient
whole
evalu
adolesc
newonset
liver
enzym
abnorm
individu
base
patient
histori
physic
exam
diseas
need
rule
adolesc
elev
liver
enzym
due
develop
chang
occur
adolesc
monitor
adher
risktak
behavior
sign
psycholog
diseas
anxieti
depress
imper
care
adolesc
liver
diseas
transit
care
adultcent
care
continu
process
throughout
adolesc
incorpor
intervent
promot
selfmanag
skill
adher
process
combin
rapid
emot
physic
chang
puberti
mani
youth
start
think
everyon
think
develop
imaginari
audienc
think
harm
adolesc
chronic
ill
newonset
ill
especi
liver
diseas
young
person
may
tri
deni
hide
ill
fear
imaginari
audienc
peer
may
find
ill
adolesc
may
tri
prove
condit
exist
audienc
real
adolesc
clinician
must
sympathet
find
solut
address
health
care
need
patient
also
social
need
psychosoci
develop
occur
adolesc
includ
establish
ident
develop
autonomi
adolesc
explor
ident
may
experi
varieti
behavior
activ
peer
group
includ
risktak
danger
behavior
patient
liver
diseas
risktak
behavior
may
involv
increas
risk
underli
diseas
also
period
patient
may
start
present
sign
symptom
psycholog
diseas
anxieti
depress
adolesc
put
emphasi
relat
fit
peer
group
chronic
liver
diseas
differ
may
caus
symptom
anxieti
depress
therefor
essenti
everi
adolesc
liver
diseas
establish
medic
home
provid
anticipatori
guidanc
health
advic
parent
patient
also
intervent
need
open
dialogu
adolesc
develop
independ
gradual
process
young
person
time
peer
group
influenc
grow
stronger
less
interest
parent
advic
howev
develop
selfmanag
adolesc
chronic
health
need
usual
lag
behind
psychosoci
develop
one
studi
look
independ
health
care
behavior
adolesc
inflammatori
bowel
diseas
report
mani
patient
year
older
still
assist
parent
similar
studi
pediatr
liver
transplant
popul
report
patient
diagnos
andor
transplant
younger
age
increas
difficulti
obtain
independ
regard
selfmanag
care
imper
clinician
foster
encourag
young
person
motiv
develop
selfmanag
skill
throughout
adolesc
care
adolesc
liver
diseas
gratifi
experi
howev
challeng
must
address
effect
care
diseas
also
patient
whole
asymptomat
peopl
elev
liver
enzym
includ
aminotransferas
alanin
aminotransferas
alt
aspart
aminotransferas
ast
gglutamyltransferas
ggt
andor
alkalin
phosphatas
extens
evalu
abnorm
test
result
would
expos
mani
patient
unnecessari
risk
expens
howev
failur
evalu
even
minor
liver
enzym
elev
persist
beyond
week
may
mean
miss
earli
diagnosi
potenti
treatabl
diseas
understand
pattern
biochem
marker
liver
injuri
one
categor
differenti
diagnos
adolesc
patient
newonset
liver
laboratori
abnorm
elev
alt
ast
suggest
liver
cell
injuri
evalu
function
liver
alt
mainli
exist
liver
found
low
concentr
tissu
howev
ast
found
multipl
tissu
includ
liver
cardiac
skelet
muscl
kidney
brain
pancrea
lung
leukocyt
erthrocyt
ast
found
sever
tissu
alt
consid
liverspecif
enzym
addit
suggest
alt
correl
degre
abdomin
adipos
aminotransferas
activ
may
elev
varieti
reason
box
review
potenti
caus
abnorm
aminotransferas
activ
nonalcohol
fatti
liver
diseas
nafld
current
one
common
caus
aminotransferas
elev
adolesc
adult
infecti
caus
elev
alt
ast
level
must
exclud
includ
viral
hepat
b
c
e
viral
infect
cytomegaloviru
cmv
epsteinbarr
viru
ebv
herp
simplex
viru
varicella
zoster
viru
bacteria
fungal
parasit
infect
metabol
caus
elev
aminotransferas
adolesc
wilson
diseas
antitrypsin
defici
hemochromatosi
cystic
fibrosi
cf
immunolog
caus
includ
autoimmun
hepat
aih
acut
fatti
liver
pregnanc
hellp
syndrom
medicationand
toxininduc
liver
injuri
uncommon
adolesc
usual
elicit
histori
confirm
demonstr
pattern
injuri
characterist
suspect
agent
liver
biopsi
caus
elev
aminotransferas
activ
includ
vascular
diseas
buddchiari
syndrom
ischem
hepat
sinusoid
obstruct
syndrom
infiltr
liver
diseas
sarcoidosi
amyloidosi
nonhepat
caus
abnorm
aminotransferas
level
includ
cardiac
diseas
thyroid
diseas
celiac
diseas
anorexia
nervosa
adren
insuffici
myopathi
strenuou
exercis
clinician
overlook
possibl
alcohol
liver
diseas
evalu
adolesc
elev
liver
enzym
drink
alcohol
risktak
activ
liver
diseas
adolesc
mani
young
adult
partak
peer
isol
eagerli
discuss
adult
alkalin
phosphatas
predomin
origin
bone
liver
also
present
small
intestin
kidney
placenta
elev
may
suggest
biliari
obstruct
bile
duct
epithelium
injuri
cholestasi
howev
isol
alkalin
phosphatas
elev
without
ggt
elev
may
caus
bone
diseas
time
increas
bone
growth
children
adolesc
alkalin
phosphatas
fraction
determin
origin
bone
liver
elev
alkalin
phosphatas
usual
liver
simultan
elev
measur
cholestasi
biliari
caus
alkalin
phosphatas
elev
includ
cholelithiasi
drug
hepatotox
primari
scleros
cholang
psc
primari
biliari
cirrhosi
addit
rare
case
benign
famili
intestin
alkalin
phosphatas
elev
ggt
present
hepatocyt
biliari
epitheli
cell
kidney
pancrea
spleen
heart
brain
semin
vesicl
ggt
sensit
marker
biliari
tract
diseas
specif
elev
six
seven
time
upper
limit
normal
adult
refer
rang
normal
fullterm
neonat
usual
decreas
normal
refer
rang
level
month
age
alcohol
drug
includ
phenytoin
phenobarbit
may
caus
ggt
elev
prothrombin
timeintern
normal
ratio
glucos
serum
albumin
test
use
evalu
synthet
function
liver
laboratori
test
evalu
patient
newonset
liver
enzym
elev
first
step
evalu
patient
newonset
liver
enzym
elev
detail
comprehens
histori
identifi
potenti
risk
factor
liver
diseas
thorough
physic
examin
look
sign
chronic
liver
diseas
workup
elev
liver
enzym
adolesc
individu
base
patient
histori
physic
examin
howev
diseas
need
rule
adolesc
elev
liver
enzym
tabl
depend
acuiti
ill
enzym
elev
infecti
caus
must
evalu
ebv
hepat
usual
caus
symptomat
acut
selflimit
hepat
howev
hepat
b
hepat
c
may
diagnos
asymptomat
patient
alway
assess
autoimmun
hepat
defici
wilson
diseas
diseas
need
rule
adolesc
elev
liver
enzym
despit
symptom
nafld
may
suspect
base
patient
growth
chart
examin
clinician
ask
recent
ill
exposur
peopl
ill
mani
virus
caus
acut
hepat
selflimit
resolv
without
sequela
druginduc
liver
injuri
high
differenti
base
patient
liver
diseas
adolesc
histori
drug
question
discontinu
immedi
patient
elev
ggt
alkalin
phosphatas
bilirubin
also
liver
ultrasound
evalu
anatom
abnorm
bile
duct
dilat
gallston
liver
mass
preval
nafld
vari
wide
depend
popul
howev
worldwid
preval
nafld
estim
median
gener
adult
popul
estim
unit
state
obes
common
welldocu
risk
factor
nafld
rise
obes
rate
unit
state
also
increas
diagnosi
nafld
lead
nonalcohol
steatohepat
cirrhosi
age
gender
ethnic
associ
vari
preval
nafld
fatti
liver
diseas
increas
age
possibl
diseas
progress
advanc
fibrosi
increas
older
patient
mani
studi
report
male
gender
risk
factor
nafld
hispan
individu
also
significantli
higher
preval
fatti
liver
diseas
compar
nonhispan
white
nonhispan
black
much
lower
preval
nafld
higher
preval
patient
metabol
syndrom
type
diabet
mellitu
dyslipidemia
patient
nafld
usual
asymptomat
may
right
upper
quadrant
pain
hepatomegali
sever
nonspecif
symptom
includ
weak
fatigu
abdomin
discomfort
mild
elev
aminotransferas
activ
hepatomegali
may
find
patient
nafld
nafld
may
suspect
base
histori
physic
examin
diagnost
gold
standard
still
liver
biopsi
sever
noninvas
method
diagnos
nafld
evalu
may
clinic
use
futur
treatment
nafld
time
lifestyl
modif
weight
loss
increas
physic
activ
help
reduc
hepat
steatosi
revers
fibrot
chang
loss
least
total
bodi
weight
need
improv
steatosi
weight
loss
may
requir
improv
necroinflamm
practic
approach
patient
suspect
fatti
liver
diseas
base
histori
elev
aminotransferas
least
month
draw
laboratori
studi
rule
diseas
aih
defici
wilson
diseas
hemochromatosi
thyroid
diseas
also
import
obtain
laboratori
studi
evalu
metabol
syndrom
high
preval
metabol
syndrom
patient
nafld
laboratori
result
point
specif
diseas
reason
defer
liver
biopsi
month
allow
patient
time
lose
weight
possibl
show
improv
aminotransferas
autoimmun
hepat
aih
chronic
hepat
caus
nonresolv
inflamm
liver
unknown
caus
character
immunolog
featur
circul
autoantibodi
onset
usual
insidi
mani
nonspecif
symptom
includ
fatigu
nausea
abdomin
pain
joint
pain
jaundic
howev
clinic
spectrum
broad
rang
asymptomat
present
present
acut
liver
failur
aih
usual
suspect
type
base
circul
autoantibodi
nuclei
andor
smooth
muscl
liverkidney
microsom
andor
liver
cytosol
antigen
patient
aih
may
also
high
serum
globulin
concentr
includ
high
igg
elev
aminotransferas
ggt
alkalin
phosphatas
bilirubin
women
affect
frequent
gender
ratio
seen
age
ethnic
group
children
aih
may
autoimmun
psc
even
without
inflammatori
bowel
diseas
import
evalu
psc
children
aih
ggt
may
better
indic
biliari
diseas
adolesc
children
alkalin
phosphatas
elev
due
bone
activ
grow
children
liver
biopsi
recommend
establish
diagnosi
aih
help
guid
treatment
interfac
hepat
common
histolog
sign
aih
may
also
plasma
cell
infiltr
lobular
inflamm
fibrosi
rare
granuloma
treatment
similar
children
adult
howev
children
diagnos
aih
start
treatment
time
diagnosi
regardless
sever
diseas
activ
children
seem
present
sever
diseas
process
standard
therapi
aih
adolesc
usual
consist
prednison
without
azathioprin
prednison
typic
taper
low
mainten
dose
first
month
treatment
provid
prompt
respons
liver
enzym
mani
side
effect
relat
use
prednison
includ
weight
gain
higher
bodi
mass
index
stunt
linear
growth
pubert
delay
import
consid
treat
adolesc
aih
budesonid
topic
steroid
azathioprin
reason
altern
treatment
fewer
side
effect
includ
less
weight
gain
lower
bodi
mass
index
may
use
maintain
remiss
adolesc
steroidrel
side
effect
azathioprin
also
use
mainten
therapi
alon
patient
abl
complet
stop
therapi
close
serolog
monitor
year
biochem
remiss
histolog
resolut
children
type
aih
abl
perman
discontinu
immunosuppress
therapi
without
diseas
recurr
rare
case
children
type
aih
diseas
refractori
standard
therapi
typic
progress
cirrhosi
may
necessit
liver
transplant
numer
infect
bacteri
viral
caus
acut
hepat
resolv
infect
caus
longterm
damag
viral
hepat
includ
hepat
b
c
e
virus
may
caus
elev
aminotransferas
hepat
e
caus
acut
selflimit
infect
spread
via
fecalor
rout
hepat
vaccin
recommend
individu
risk
travel
current
vaccin
hepat
e
convers
hepat
b
c
usual
present
adolesc
chronic
infect
aminotransferas
activ
typic
elev
acut
viral
hepat
may
closer
normal
chronic
hepat
especi
hepat
c
hepat
b
viru
hbv
may
vertic
transmit
mother
babi
contact
blood
bodi
fluid
infect
person
hbv
may
caus
symptomat
acut
hepat
within
first
month
infect
mani
individu
complet
asymptomat
clear
viru
within
month
contract
children
contract
viru
year
age
develop
chronic
hepat
risk
chronic
infect
patient
vertic
acquir
hepat
b
approach
treatment
avail
acut
hepat
b
treatment
regimen
chronic
hbv
vaccin
hepat
b
mainstay
hepat
b
prevent
hepat
caus
acut
chronic
infect
replic
patient
hbv
infect
hepat
c
viru
hcv
bloodborn
viru
caus
acut
chronic
infect
may
also
vertic
transmit
liver
diseas
adolesc
patient
infect
hepat
c
develop
chronic
hcv
hepat
c
vaccin
multipl
treatment
avail
adolesc
patient
hbv
hcv
acquir
viru
via
vertic
transmiss
howev
highrisk
behavior
young
adult
particip
import
test
hbv
hcv
evalu
adolesc
elev
liver
enzym
even
test
neg
past
system
viral
infect
also
caus
abnorm
aminotransferas
level
elev
alt
ast
caus
ebv
frequent
seen
conjunct
acut
mononucleosi
posit
monospot
test
usual
selflimit
howev
ebv
serolog
may
need
evalu
monospot
test
neg
high
sensit
may
neg
earli
cours
ebv
infect
jaundic
occur
less
children
ebv
infect
cmv
infect
immunecompet
patient
gener
present
subclin
case
selfresolv
dissemin
cmv
infect
immunecompromis
patient
may
caus
sever
organ
damag
mortal
herp
simplex
viru
predominantli
diagnos
neonat
pregnant
immunecompromis
patient
present
fulmin
hepat
high
mortal
wilson
diseas
inherit
autosomalrecess
metabol
diseas
lead
impair
cellular
copper
transport
defect
gene
encod
hepat
coppertransport
protein
play
key
role
human
copper
metabol
defect
result
decreas
copper
transport
liver
bile
caus
excess
copper
accumul
sever
organ
notabl
liver
brain
cornea
kidney
excess
hepat
copper
lead
hepatocyt
damag
worldwid
preval
wilson
diseas
approxim
live
birth
slight
male
predomin
patient
wilson
diseas
diagnos
age
year
may
present
hepat
neurolog
andor
psychiatr
symptom
children
usual
present
liver
diseas
age
year
hepat
manifest
wilson
diseas
vari
greatli
consist
asymptomat
laboratori
abnorm
steatosi
acut
hepat
acut
liver
failur
associ
coombsneg
hemolyt
anemia
chronic
hepat
cirrhosi
biochem
abnorm
may
includ
elev
aminotransferas
low
serum
ceruloplasmin
elev
urinari
copper
coombsneg
hemolyt
anemia
thrombocytopenia
coagulopathi
addit
sign
symptom
associ
hepat
wilson
diseas
kayserfleisch
ring
patient
hepat
diseas
diagnos
slitlamp
examin
abdomin
pain
hepatomegali
jaundic
splenomegali
ascit
upper
gastrointestin
bleed
mental
statu
chang
caus
hepat
encephalopathi
liver
biopsi
show
high
hepat
copper
concentr
treatment
wilson
diseas
life
long
involv
remov
tissu
copper
accumul
prevent
reaccumul
excess
copper
potent
copper
chelat
trienten
dpenicillamin
moder
dose
use
treat
copper
overload
wherea
low
dose
use
help
prevent
copper
accumul
patient
also
maintain
lowcopp
diet
avoid
copperrich
food
chocol
shellfish
nut
mushroom
unprocess
wheat
dietari
copper
intak
gener
diet
mg
per
day
recommend
daili
copper
intak
mg
per
day
healthi
individu
patient
present
acut
liver
failur
may
requir
liver
transplant
firstdegre
rel
patient
newli
diagnos
wilson
diseas
need
screen
wilson
diseas
antitrypsin
defici
defici
underrecogn
disord
affect
lung
liver
rare
skin
common
known
genet
caus
liver
diseas
lead
pediatr
liver
transplant
serum
glycoprotein
synthes
mainli
liver
larg
quantiti
secret
serum
physiolog
function
inhibit
neutrophil
proteas
releas
period
inflamm
protect
host
tissu
nonspecif
injuri
mani
known
mutat
gene
patient
liver
diseas
homozyg
z
mutant
allel
pi
zz
occur
approxim
birth
north
american
european
popul
mutant
z
gene
direct
synthesi
mutant
protein
abnorm
fold
retain
intracellularli
within
hepatocyt
rather
excret
accumul
mutant
protein
within
hepatocyt
trigger
cascad
chronic
hepatocellular
apoptosi
regener
endorgan
injuri
lead
liver
injuri
cirrhosi
hepatocelllular
carcinoma
given
right
environment
trigger
patient
may
present
neonat
hepat
cholestasi
adolesc
elev
aminotransferas
elev
ggt
hepatomegali
mild
liver
diseas
diagnosi
continu
progress
advanc
liver
diseas
current
medic
treatment
liver
transplant
may
use
treat
patient
endstag
liver
diseas
biliari
atresia
ba
idiopath
progress
oblit
diseas
extrahepat
biliari
tree
present
neonat
biliari
obstruct
common
indic
liver
transplant
children
overal
incid
live
birth
new
case
per
year
unit
state
diagnos
ba
kasai
procedur
promptli
perform
enhanc
flow
bile
less
half
patient
ba
make
adolesc
nativ
liver
outcom
adult
ba
nativ
liver
year
promis
normal
pubert
develop
greater
achiev
normal
averag
height
addit
particip
standard
daili
activ
includ
hold
employ
enrol
school
marri
even
posit
outcom
report
depress
heavi
drinker
hepat
complic
associ
ba
postkasai
includ
portal
hypertens
ptn
cirrhosi
gastrointestin
bleed
late
bacteri
cholang
coagulopathi
pruriti
ptn
recurr
cholang
frequent
complic
high
morbid
mortal
necessit
need
liver
transplant
ptn
may
occur
twothird
longterm
survivor
patient
ba
nativ
liver
often
defin
complic
ptn
gastrointestin
bleed
endoscop
find
varic
noninvas
marker
ptn
includ
splenomegali
thrombocytopenia
low
albumin
endoscop
therapi
avail
patient
varic
bleed
includ
band
sclerotherapi
octreotid
usual
effect
immedi
medic
manag
longterm
therapi
patient
low
bilirubin
varic
hemorrhag
better
prognosi
patient
higher
bilirubin
level
varic
bleed
select
patient
compens
liver
diseas
varic
bleed
refractori
medic
endoscop
therapi
transjugular
intrahepat
portosystem
shunt
mayb
viabl
altern
bridg
liver
transplant
cholang
anoth
common
complic
defin
fever
achol
stool
elev
liver
enzym
uncommon
patient
suspect
cholang
neg
blood
cultur
cholang
caus
enter
pathogen
includ
escherichia
coli
enterobact
klebsiella
treat
effect
cephalosporin
aminoglycosid
levofloxacin
howev
recurr
cholang
increas
risk
varic
hemorrhag
thu
need
evalu
liver
transplant
adolesc
patient
ba
nativ
liver
eventu
need
liver
transplant
cf
common
diseas
incid
live
birth
current
life
expect
year
less
onethird
patient
cf
clinic
signific
liver
diseas
male
predomin
patient
cf
liver
diseas
patient
cf
liver
diseas
note
steatosi
wherea
cholithiasi
roughli
focal
multilobular
biliari
cirrhosi
cf
liver
diseas
primarili
diagnos
patient
sever
cf
transmembran
regul
mutat
absenc
cf
transmembran
regul
function
caus
dehydr
concentr
decreas
alkalin
duct
content
produc
precipit
biliari
secret
lead
biliari
obstruct
inflamm
caus
biliari
cirrhosi
liver
enzym
good
indic
hepat
injuri
patient
cf
liver
diseas
intermitt
abnorm
laboratori
studi
includ
elev
aminotransferas
ggt
elev
bilirubin
uncommon
minim
treatment
option
cf
liver
diseas
ursodeoxychol
acid
may
improv
bile
flow
liver
enzym
postul
may
cytoprotect
effect
patient
progress
biliari
cirrhosi
multilobular
cirrhosi
ptn
overal
develop
ascit
varic
transjugular
intrahepat
portosystem
shunt
band
effect
therapi
ptn
secondari
cf
liver
diseas
bblocker
may
caus
bronchospasm
good
treatment
choic
liver
transplant
reserv
patient
sever
synthet
liver
dysfunct
patient
cf
also
increas
risk
gastrointestin
tract
malign
third
hepat
biliari
tract
origin
risk
increas
age
peak
third
decad
psc
chronic
progress
cholestat
liver
diseas
unknown
caus
character
inflamm
fibrosi
intrahepat
extrahepat
bile
duct
lead
format
multifoc
bile
duct
strictur
patient
psc
underli
ulcer
coliti
howev
patient
ulcer
coliti
psc
mani
patient
present
psc
childhood
adolesc
develop
symptom
suggest
ulcer
coliti
later
life
slight
male
predomin
half
patient
asymptomat
time
present
may
nonspecif
symptom
fatigu
pruritu
biochem
abnorm
includ
elev
alkalin
phosphatas
mildli
elev
aminotransferas
physic
examin
may
reveal
jaundic
hepatomegali
splenomegali
excori
psc
diagnos
cholangiographi
liver
biopsi
alway
requir
prove
treatment
slow
progress
diseas
mani
medic
surgic
therapi
treat
pruritu
strictur
complic
psc
liver
transplant
may
consid
patient
advanc
diseas
alagil
syndrom
autosomaldomin
inherit
diseas
cholestasi
common
disord
associ
bile
duct
pauciti
incid
live
birth
half
patient
de
novo
mutat
notch
gene
variabl
penetr
phenotyp
express
patient
usual
diagnos
infant
note
direct
hyperbilirubinemia
elev
aminotransferas
disproport
elev
ggt
common
clinic
featur
includ
chronic
cholestasi
cardiac
anomali
butterfli
vertebra
posterior
embryotoxon
eye
dysmorph
faci
consist
triangular
faci
deepset
eye
broad
nasal
bridg
patient
may
also
renal
diseas
pancreat
insuffici
development
delay
short
statur
intracrani
hemorrhag
vascular
anomali
multipl
organ
includ
central
nervou
system
common
risk
intracrani
hemorrhag
associ
mortal
bleed
respond
well
surgic
clip
ligat
treatment
alagil
syndrom
involv
manag
differ
diseas
affect
organ
system
progress
famili
intrahepat
cholestasi
pfic
heterogen
group
disord
defin
defect
secret
bile
acid
compon
bile
disord
usual
present
infanc
cholestasi
coagulopathi
caus
vitamin
k
malabsorpt
elev
aminotransferas
normal
nearli
normal
ggt
pfic
pfic
pfic
associ
growth
failur
progress
liver
diseas
pfic
autosomalrecess
distinguish
missens
mutat
gene
patient
pfic
usual
present
within
first
year
life
low
normal
ggt
intens
pruritu
progress
biliari
cirrhosi
variabl
may
respond
biliari
divers
improv
pruritu
slow
progress
liver
diseas
pfic
caus
defect
gene
encod
bsep
atpdepend
bile
acid
transport
bsep
activ
transport
bile
acid
across
canalicular
membran
bile
absenc
bsep
function
lead
low
serum
ggt
low
cholesterol
chronic
intrahepat
cholestasi
progress
cirrhosi
usual
first
year
life
patient
pfic
increas
risk
cancer
hepatocellular
carcinoma
common
form
cholangiocarcinoma
pancreat
adenocarcinoma
may
also
occur
pfic
involv
mutat
gene
encod
absenc
result
failur
phospholipid
transport
bile
patient
pfic
note
high
ggt
liver
biopsi
show
ductal
prolifer
depend
mutat
patient
may
present
clinic
cholestasi
earli
childhood
may
present
milder
form
diseas
older
age
pruritu
usual
milder
pfic
diseas
still
progress
endstag
liver
diseas
treatment
patient
pfic
involv
address
nutrit
defici
includ
fatsolubl
vitamin
supplement
pruritu
ursodeoxychol
acid
might
improv
mild
pruriti
howev
sever
pruriti
often
refractori
medic
therapi
requir
surgeri
biliari
divers
biliari
divers
may
help
pruriti
might
also
improv
biochem
abnorm
slow
progress
liver
diseas
liver
transplant
feasibl
option
patient
endstag
liver
diseas
pruritu
refractori
medic
surgic
therapi
benign
recurr
intrahepat
cholestasi
opposit
end
spectrum
pfic
caus
mutat
gene
gene
caus
pfic
benign
recurr
intrahepat
cholestasi
autosomalrecess
diseas
defin
intermitt
episod
cholestasi
patient
may
present
age
includ
adolesc
frequenc
episod
wide
variabl
episod
patient
present
conjug
hyperbilirubinemia
pruritu
anorexia
malais
episod
may
last
week
month
complet
clinic
liver
diseas
adolesc
biochem
histolog
normal
treatment
benign
recurr
intrahepat
cholestasi
frequenc
episod
seem
decreas
age
care
adolesc
liver
diseas
far
challeng
age
group
clinician
must
juggl
manag
complex
liver
diseas
fulli
consid
patient
psychosoci
health
young
peopl
undergo
major
chang
psychosoci
physic
develop
time
tri
gain
independ
adolesc
unfortun
progress
selfmanag
skill
usual
lag
behind
psychosoci
develop
pediatr
clinician
parent
alway
tune
need
guid
adolesc
develop
selfmanag
skill
selfmanag
skill
includ
adher
treatment
regimen
take
respons
medic
get
requir
blood
test
time
manner
schedul
attend
appoint
recogn
sign
symptom
suggest
chang
health
statu
typic
chronolog
age
frequent
use
criteria
determin
patient
readi
somewhat
abrupt
transit
childcent
health
care
adultcent
health
care
howev
studi
shown
respons
healthrel
task
gradual
shift
throughout
adolesc
development
appropri
manner
adolesc
gain
skill
knowledg
experi
necessari
master
selfmanag
skill
independ
requir
success
adult
health
care
system
adher
key
compon
develop
selfmanag
skill
univers
concern
care
adolesc
consider
literatur
discuss
psychosoci
factor
predict
nonadher
factor
includ
famili
interact
psycholog
symptom
patient
barrier
adher
behavior
diseas
process
level
selfmanag
skill
care
pattern
includ
time
frequenc
medic
clinic
appoint
socioeconom
statu
howev
strategi
improv
adher
consist
simplifi
treatment
regimen
assess
address
common
risk
factor
obstacl
adher
leverag
electron
devic
provid
remind
text
messag
alarm
medic
remain
connect
patient
frequent
followup
appropri
psychosoci
support
essenti
patient
famili
diagnos
liver
diseas
especi
chronic
liver
diseas
increas
bodi
literatur
report
symptom
anxieti
signific
stress
posttraumat
stress
disord
patient
parent
diagnos
perceiv
actual
lifethreaten
ill
addit
number
complic
associ
diseas
correl
psycholog
symptom
one
studi
report
children
nafld
higher
level
depress
compar
obes
control
subject
depress
necessarili
improv
standard
care
measur
lifestyl
chang
weight
loss
also
report
chronic
ill
childhood
impact
cognit
associ
limit
school
increas
miss
school
day
thu
provid
consid
schedul
routin
followup
adolesc
time
interfer
school
attend
transit
pediatriccent
health
care
adultcent
health
care
part
development
process
patient
chronic
childhood
ill
requir
multidisciplinari
approach
transit
care
transfer
care
transfer
care
one
small
step
transit
care
adult
health
care
system
mark
end
transit
process
transit
care
begin
around
year
depend
development
matur
patient
multifacet
process
address
medic
psychosoci
educ
need
adolesc
prepar
move
pediatriccent
health
care
adultcent
health
care
transfer
care
adult
health
care
system
patient
must
achiev
transfer
readi
includ
understand
ill
selfmanag
skill
abil
assum
respons
health
care
addit
help
identifi
adult
health
care
provid
group
least
month
transfer
work
close
transfer
may
includ
joint
clinic
appoint
schedul
appoint
adult
care
provid
becom
familiar
practic
expect
adult
health
care
system
still
follow
pediatr
health
care
provid
transit
prepar
continu
process
incorpor
intervent
promot
selfmanag
skill
adher
pediatr
patient
prepar
move
childcent
care
adultcent
care
ensur
success
transfer
care
